Caveolae and Bin1 form ring-shaped platforms for T-tubule initiation

  1. Eline Lemerle
  2. Jeanne Lainé
  3. Marion Benoist
  4. Gilles Moulay
  5. Anne Bigot
  6. Clémence Labasse
  7. Angéline Madelaine
  8. Alexis Canette
  9. Perrine Aubin
  10. Jean-Michel Vallat
  11. Norma B Romero
  12. Marc Bitoun
  13. Vincent Mouly
  14. Isabelle Marty
  15. Bruno Cadot
  16. Laura Picas
  17. Stéphane Vassilopoulos  Is a corresponding author
  1. Sorbonne Université, INSERM, France
  2. Pitié-Salpêtrière Hospital, France
  3. Sorbonne Université, France
  4. University Grenoble Alpes, INSERM, France
  5. University Hospital, France
  6. CNRS UMR 9004, Université de Montpellier, France

Abstract

Excitation-contraction coupling requires a highly specialized membrane structure, the triad, composed of a plasma membrane invagination, the T-tubule, surrounded by two sarcoplasmic reticulum terminal cisternae. Although the precise mechanisms governing T-tubule biogenesis and triad formation remain largely unknown, studies have shown that caveolae participate in T-tubule formation and mutations of several of their constituents induce muscle weakness and myopathies. Here, we demonstrate that, at the plasma membrane, Bin1 and caveolae composed of caveolin-3 assemble into ring-like structures from which emerge tubes enriched in the dihydropyridine receptor. Bin1 expression lead to the formation of both rings and tubes and we show that Bin1 forms scaffolds on which caveolae accumulate to form the initial T-tubule. Cav3 deficiency caused by either gene silencing or pathogenic mutations results in defective ring formation and perturbed Bin1-mediated tubulation that may explain defective T-tubule organization in mature muscles. Our results uncover new pathophysiological mechanisms that may prove relevant to myopathies caused by Cav3 or Bin1 dysfunction.

Data availability

All datasets supporting the findings of this study are available in Dryad

The following data sets were generated

Article and author information

Author details

  1. Eline Lemerle

    Institut de Myologie, Sorbonne Université, INSERM, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Jeanne Lainé

    Institut de Myologie, Sorbonne Université, INSERM, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Marion Benoist

    Institut de Myologie, Sorbonne Université, INSERM, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Gilles Moulay

    Institut de Myologie, Sorbonne Université, INSERM, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Anne Bigot

    Institut de Myologie, Sorbonne Université, INSERM, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Clémence Labasse

    Neuromuscular Morphology Unit, Pitié-Salpêtrière Hospital, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Angéline Madelaine

    Neuromuscular Morphology Unit, Pitié-Salpêtrière Hospital, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Alexis Canette

    Institut de Biologie Paris-Seine, Sorbonne Université, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2750-6568
  9. Perrine Aubin

    Grenoble Institut des Neurosciences, University Grenoble Alpes, INSERM, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Jean-Michel Vallat

    Department of Neurology, University Hospital, Limoges, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Norma B Romero

    Neuromuscular Morphology Unit, Pitié-Salpêtrière Hospital, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Marc Bitoun

    Institut de Myologie, Sorbonne Université, INSERM, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Vincent Mouly

    Institut de Myologie, Sorbonne Université, INSERM, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  14. Isabelle Marty

    Grenoble Institut des Neurosciences, University Grenoble Alpes, INSERM, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  15. Bruno Cadot

    Institut de Myologie, Sorbonne Université, INSERM, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  16. Laura Picas

    Institut de Recherche en Infectiologie de Montpellier (IRIM), CNRS UMR 9004, Université de Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5619-5228
  17. Stéphane Vassilopoulos

    Institut de Myologie, Sorbonne Université, INSERM, Paris, France
    For correspondence
    s.vassilopoulos@institut-myologie.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0172-330X

Funding

Agence Nationale de la Recherche (ANR-21-CE13-0018-01)

  • Stéphane Vassilopoulos

Agence Nationale de la Recherche (ANR-18-CE17-0006-02)

  • Marc Bitoun

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Animal studies conform to the French laws and regulations concerning the use of animals for research and were approved by an external ethics committee (approval no. 00351.02 delivered by the French Ministry of Higher Education and Scientific Research).

Human subjects: For human studies, all individuals provided informed consent for muscle biopsies according to a protocol approved by the ethics committee of the Centre de Référence de Pathologie Neuromusculaire Paris-Est, Institut de Myologie, Assistance Publique-Hôpitaux de Paris, GH Pitié-Salpêtrière, Paris, France.

Copyright

© 2023, Lemerle et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,862
    views
  • 290
    downloads
  • 22
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Eline Lemerle
  2. Jeanne Lainé
  3. Marion Benoist
  4. Gilles Moulay
  5. Anne Bigot
  6. Clémence Labasse
  7. Angéline Madelaine
  8. Alexis Canette
  9. Perrine Aubin
  10. Jean-Michel Vallat
  11. Norma B Romero
  12. Marc Bitoun
  13. Vincent Mouly
  14. Isabelle Marty
  15. Bruno Cadot
  16. Laura Picas
  17. Stéphane Vassilopoulos
(2023)
Caveolae and Bin1 form ring-shaped platforms for T-tubule initiation
eLife 12:e84139.
https://doi.org/10.7554/eLife.84139

Share this article

https://doi.org/10.7554/eLife.84139

Further reading

    1. Cancer Biology
    2. Cell Biology
    Ida Marie Boisen, Nadia Krarup Knudsen ... Martin Blomberg Jensen
    Research Article

    Testicular microcalcifications consist of hydroxyapatite and have been associated with an increased risk of testicular germ cell tumors (TGCTs) but are also found in benign cases such as loss-of-function variants in the phosphate transporter SLC34A2. Here, we show that fibroblast growth factor 23 (FGF23), a regulator of phosphate homeostasis, is expressed in testicular germ cell neoplasia in situ (GCNIS), embryonal carcinoma (EC), and human embryonic stem cells. FGF23 is not glycosylated in TGCTs and therefore cleaved into a C-terminal fragment which competitively antagonizes full-length FGF23. Here, Fgf23 knockout mice presented with marked calcifications in the epididymis, spermatogenic arrest, and focally germ cells expressing the osteoblast marker Osteocalcin (gene name: Bglap, protein name). Moreover, the frequent testicular microcalcifications in mice with no functional androgen receptor and lack of circulating gonadotropins are associated with lower Slc34a2 and higher Bglap/Slc34a1 (protein name: NPT2a) expression compared with wild-type mice. In accordance, human testicular specimens with microcalcifications also have lower SLC34A2 and a subpopulation of germ cells express phosphate transporter NPT2a, Osteocalcin, and RUNX2 highlighting aberrant local phosphate handling and expression of bone-specific proteins. Mineral disturbance in vitro using calcium or phosphate treatment induced deposition of calcium phosphate in a spermatogonial cell line and this effect was fully rescued by the mineralization inhibitor pyrophosphate. In conclusion, testicular microcalcifications arise secondary to local alterations in mineral homeostasis, which in combination with impaired Sertoli cell function and reduced levels of mineralization inhibitors due to high alkaline phosphatase activity in GCNIS and TGCTs facilitate osteogenic-like differentiation of testicular cells and deposition of hydroxyapatite.

    1. Cell Biology
    Affiong Ika Oqua, Kin Chao ... Alejandra Tomas
    Research Article

    G protein-coupled receptors (GPCRs) are integral membrane proteins which closely interact with their plasma membrane lipid microenvironment. Cholesterol is a lipid enriched at the plasma membrane with pivotal roles in the control of membrane fluidity and maintenance of membrane microarchitecture, directly impacting on GPCR stability, dynamics, and function. Cholesterol extraction from pancreatic beta cells has previously been shown to disrupt the internalisation, clustering, and cAMP responses of the glucagon-like peptide-1 receptor (GLP-1R), a class B1 GPCR with key roles in the control of blood glucose levels via the potentiation of insulin secretion in beta cells and weight reduction via the modulation of brain appetite control centres. Here, we unveil the detrimental effect of a high cholesterol diet on GLP-1R-dependent glucoregulation in vivo, and the improvement in GLP-1R function that a reduction in cholesterol synthesis using simvastatin exerts in pancreatic islets. We next identify and map sites of cholesterol high occupancy and residence time on active vs inactive GLP-1Rs using coarse-grained molecular dynamics (cgMD) simulations, followed by a screen of key residues selected from these sites and detailed analyses of the effects of mutating one of these, Val229, to alanine on GLP-1R-cholesterol interactions, plasma membrane behaviours, clustering, trafficking and signalling in INS-1 832/3 rat pancreatic beta cells and primary mouse islets, unveiling an improved insulin secretion profile for the V229A mutant receptor. This study (1) highlights the role of cholesterol in regulating GLP-1R responses in vivo; (2) provides a detailed map of GLP-1R - cholesterol binding sites in model membranes; (3) validates their functional relevance in beta cells; and (4) highlights their potential as locations for the rational design of novel allosteric modulators with the capacity to fine-tune GLP-1R responses.